Results 221 to 230 of about 173,723 (245)
Some of the next articles are maybe not open access.

Other pharmacological treatments for motor complications and dyskinesias

Movement Disorders, 2005
Controlling motor complications becomes increasingly difficult with disease progression. The "wearing-off" phenomenon is the most-common motor fluctuation. Wearing-off can be treated by dietary manipulation, shortening the dosing interval, substituting sustained-release levodopa, adding amantadine, or monoamine oxidase type B inhibitors, and other ...
openaire   +2 more sources

Brief, Complicated Motor Seizure

Psychiatry and Clinical Neurosciences, 1989
S, Kobayashi   +5 more
openaire   +2 more sources

Presynaptic Mechanisms of Motor Complications in Parkinson Disease

Archives of Neurology, 2007
T HE PATHOGENESIS OF levodopa-related motor complications (motor fluctuations and dyskinesias) is still far from clear, but there is converging evidence to suggest that presynaptic mechanisms play a major role. In fact, we have recently developed a mathematical probability model that can accommodate the whole spectrum of motor complications often seen ...
openaire   +2 more sources

Advancing Parkinson’s Disease and Treatment of Motor Complications

2000
This chapter addresses issues related to the diagnosis and treatment of motor dysfunction in advancing Parkinson’s disease (PD). The format, designed for use by the clinician, identifies keys to a pertinent history and physical examination and suggests treatment strategies for specific clinical situations. A discussion of other practical issues follows
openaire   +1 more source

Clinical strategies to prevent and delay motor complications

Neurology, 2003
Current evidence suggests that motor complications associated with long-term L-dopa treatment in patients with Parkinson's disease (PD) are the consequence of two factors: the disease course, with progressive destruction of dopaminergic terminals, and the pulsatile nonphysiologic stimulation of dopamine receptors caused by multiple administrations of L-
openaire   +2 more sources

PET studies and motor complications in Parkinson's disease

Trends in Neurosciences, 2000
Parkinson's disease (PD) patients with motor complications show a greater reduction in putamen [18F]dopa uptake on positron emission tomography (PET) compared with sustained responders to L-dopa, although individual ranges overlap considerably. This implies that, although loss of putamen dopamine storage predisposes motor complications in PD, it cannot
openaire   +2 more sources

Herpes Zoster Infection Complicated by Motor Paralysis

The Journal of Dermatology, 2000
AbstractWe reviewed a total of 1,432 patients diagnosed with cutaneus herpes zoster at Hyogo College of Medicine Hospital between 1989 and 1997 for epidemiologic assessment and outcome in patients with zoster paralysis referred for rehabilitation. Of the 1,432 herpes zoster patients (624 males and 808 females, mean age 54.3 years), 12 were referred to ...
openaire   +2 more sources

Altered gut microbiota in Parkinson's disease patients with motor complications

Parkinsonism and Related Disorders, 2022
Kazuhiro Iwaoka   +2 more
exaly  

Evaluation of Motor Complications: Motor Fluctuations

2012
Marcelo Merello, Angelo Antonini
openaire   +1 more source

Home - About - Disclaimer - Privacy